UK markets closed

Bioceltix S.A. (XI3.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
12.44-0.16 (-1.27%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
10.8
-
Cost of revenue
1,178
1,038
699.9939
853.8647
478.5469
-
Gross profit
-1,178
-1,038
-699.9939
-853.8647
-467.7469
-
Operating expenses
Selling general and administrative
11,016
9,426
5,210
2,940
1,952
-
Total operating expenses
14,446
12,977
8,255
3,550
1,911
-
Operating income or loss
-15,624
-14,015
-8,955
-4,404
-2,379
-
Interest expense
34.1021
33.6471
31.5067
22.9502
17.0203
-
Income before tax
-15,270
-13,693
-8,967
-4,356
-2,366
-
Income tax expense
-9.5008
-5.2699
-46.101
41.5183
-17.0355
-
Income from continuing operations
-15,261
-13,688
-8,921
-4,398
-2,349
-
Net income
-15,261
-13,688
-8,921
-4,398
-2,349
-
Net income available to common shareholders
-15,261
-13,688
-8,921
-4,398
-2,349
-
Basic EPS
-3.50
-
-2.67
-1.39
-0.95
-0.49
Diluted EPS
-3.50
-
-2.67
-1.39
-0.95
-0.49
Basic average shares
3,638
-
3,336
3,161
3,287
3,287
Diluted average shares
3,638
-
3,336
3,161
3,287
3,287